
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
NONE. Menrva holds no usable description for this book. Unless you genuinely and specifically know this published work, set sufficient_material=false. Do NOT infer a plot, characters, or contents from the title.
This book investigates the complex molecular signaling pathways that drive the etiology of liver cancer and explores the landscape of targeted therapeutic strategies. It synthesizes current research on the genetic and environmental factors contributing to hepatocellular carcinoma (HCC) and other liver malignancies, detailing the aberrant cellular processes involved. The work then critically examines novel and established targeted therapies designed to disrupt these specific pathways, offering insights into their mechanisms of action, clinical efficacy, and future potential.
This text is positioned as a specialized scientific monograph for researchers and clinicians in the field of oncology and hepatology. Its detailed examination of molecular pathways and targeted therapies suggests a dense, technical approach aimed at specialists. The scope indicates a comprehensive overview of current knowledge and future research avenues in liver cancer treatment.
Page Count:
120
Publication Date:
2024-10-15
Publisher:
LAP LAMBERT Academic Publishing
ISBN-10:
6208222532
ISBN-13:
9786208222536
No comments yet. Be the first to share your thoughts!